Music, movies, books, plants, cats and dogs.
1/ Hey #NephSky! 👋
We’re back with a fresh #Skeetorial from @kireports.bsky.social , this time diving into:
Dapagliflozin in Stage 4 CKD: no diabetes required? 🤔
Let’s unpack what this trial means for your next CKD patient. 💊💭
1/ Hey #NephSky! 👋
We’re back with a fresh #Skeetorial from @kireports.bsky.social , this time diving into:
Dapagliflozin in Stage 4 CKD: no diabetes required? 🤔
Let’s unpack what this trial means for your next CKD patient. 💊💭
Simultaneous pub in NEJM
www.nejm.org/doi/full/10....
Check out ✅ “IgAN: An Overview of the Clinical Trials” ca. 2025 from @kidneymed.bsky.social @alexgr23.bsky.social @saynanorouzi.bsky.social
#Nephpearls #NephSky #KidneyWk #IgAN
👉 pubmed.ncbi.nlm.nih.gov/41050133/
Check out ✅ “IgAN: An Overview of the Clinical Trials” ca. 2025 from @kidneymed.bsky.social @alexgr23.bsky.social @saynanorouzi.bsky.social
#Nephpearls #NephSky #KidneyWk #IgAN
👉 pubmed.ncbi.nlm.nih.gov/41050133/
finerenone vs spiro - a trial emulation
Would love to know your thoughts on this paper @hswapnil.medsky.social
finerenone vs spiro - a trial emulation
Would love to know your thoughts on this paper @hswapnil.medsky.social
A @nature.com paper today tells the story, one with big implications, as reviewed here
erictopol.substack.com/p/how-mrna-v...
A @nature.com paper today tells the story, one with big implications, as reviewed here
erictopol.substack.com/p/how-mrna-v...
Determining sample size for pilot trials: a tutorial
www.bmj.com/content/bmj/...
Determining sample size for pilot trials: a tutorial
www.bmj.com/content/bmj/...
#nephsky
#nephsky
@kidneyboy.bsky.social
@kidneyboy.bsky.social
🔻 15% all-cause hospitalizations
✅ Consistent regardless of eGFR, UACR & diabetes
🏥 ~36 fewer hospitalizations per 1000 pt-years
Large absolute gains for patients & health systems
Meta-analysis in @asnpublications.bsky.social
journals.lww.com/cjasn/pages/...
🔻 15% all-cause hospitalizations
✅ Consistent regardless of eGFR, UACR & diabetes
🏥 ~36 fewer hospitalizations per 1000 pt-years
Large absolute gains for patients & health systems
Meta-analysis in @asnpublications.bsky.social
journals.lww.com/cjasn/pages/...
#nephjc Raghunath, nephrologist from Kerala, India. No COI. Mostly lurking and learning.
#nephjc Raghunath, nephrologist from Kerala, India. No COI. Mostly lurking and learning.
Rtx or CNI or MMF?
Rtx or CNI or MMF?
youtu.be/qFYVhjpnYIU?...
#OncoNeph #NephSky
youtu.be/qFYVhjpnYIU?...
#OncoNeph #NephSky
When you have ⬆️K, is there a rule as to how much aldo should rise? i hv a pt with K consistently around 5.5 and aldo level 14.2ng/dl, DRC 1.33mIU/ml, would you say that the aldo is inappropriately nrml & this is hyporeninemic hypoaldo?
@kidneyboy.bsky.social @hswapnil.medsky.social
When you have ⬆️K, is there a rule as to how much aldo should rise? i hv a pt with K consistently around 5.5 and aldo level 14.2ng/dl, DRC 1.33mIU/ml, would you say that the aldo is inappropriately nrml & this is hyporeninemic hypoaldo?
@kidneyboy.bsky.social @hswapnil.medsky.social